Ryoji Hayashi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ryoji Hayashi has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
Masafumi Isogaya
Pharmaceutical Research Laboratories, Toray Industries, Inc., 6-10-1 Tebiro, Kamakura, Kanagawa 248-8555, Japan
5 shared publicationsMitsuhiro Moriwaki
Pharmaceutical Research Laboratories, Toray Industries, Inc., 6-10-1 Tebiro, Kamakura, Kanagawa 248-8555, Japan
3 shared publicationsEiji Ohmori
Pharmaceutical Research Laboratories, Toray Industries, Inc., 6-10-1 Tebiro, Kamakura, Kanagawa 248-8555, Japan
2 shared publicationsHiroaki Ito
Pharmaceutical Research Laboratories, Toray Industries, Inc., 6-10-1 Tebiro, Kamakura, Kanagawa 248-8555, Japan
2 shared publications- Hiroki Kumagai
Pharmaceutical Research Laboratories, Toray Industries, Inc., 6-10-1 Tebiro, Kamakura, Kanagawa 248-8555, Japan
2 shared publications Mitsuko Miyamoto
Pharmaceutical Research Laboratories, Toray Industries, Inc., 6-10-1 Tebiro, Kamakura, Kanagawa 248-8555, Japan
2 shared publications
Latest Publications
- 1 June 2016
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 26 (12) , 2886-2889
Piperidine derivatives as nonprostanoid IP receptor agonists 2
- 1 June 2016
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 26 (12) , 2886-2889
Piperidine derivatives as nonprostanoid IP receptor agonists 2
- 1 May 2016
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 26 (9) , 2360-2364
Piperidine derivatives as nonprostanoid IP receptor agonists
- 1 May 2016
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 26 (9) , 2360-2364
Piperidine derivatives as nonprostanoid IP receptor agonists
- 1 September 2015
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 25 (18) , 3921-3923
Indolylpiperidine derivatives as potent and selective α1B adrenoceptor antagonists
- 1 September 2015
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 25 (18) , 3921-3923
Indolylpiperidine derivatives as potent and selective α1B adrenoceptor antagonists
- 31 May 2015
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 25 (16) , 3368-3372
Discovery of potent α1L-adrenoceptor agonists: Design and synthesis of bicyclic derivatives
- 31 May 2015
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 25 (16) , 3368-3372
Discovery of potent α1L-adrenoceptor agonists: Design and synthesis of bicyclic derivatives
- 1 September 2014
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 24 (18) , 4603-4606
The discovery of potent glycine transporter type-2 inhibitors: Design and synthesis of phenoxymethylbenzamide derivatives
- 1 September 2014
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 24 (18) , 4603-4606
The discovery of potent glycine transporter type-2 inhibitors: Design and synthesis of phenoxymethylbenzamide derivatives
- Open Access
Synthesis of Novel IP Agonists via N-Aminoethyl Cyclic Amines Prepared by Decarboxylative Ring-Opening Reactions
An efficient synthesis of a highly potent and selective IP (PGI2 receptor) agonist that is not structurally analogous to PGI2 is described. This synthesis is accomplished through the following key steps: Nucleophilic ring-opening of 3-(4-chlorophenyl)-oxazolidin-2-one prepared by a one-pot procedure with 4-piperidinol and selective O-alkylation of 1-(2-(4-chlorophenylamino)ethyl)piperidin-4-ol. The obtained compound is a potent and selective IP agonist displaying a long duration of action.
Open AccessSynthesis of Novel IP Agonists via N-Aminoethyl Cyclic Amines Prepared by Decarboxylative Ring-Opening Reactions
An efficient synthesis of a highly potent and selective IP (PGI2 receptor) agonist that is not structurally analogous to PGI2 is described. This synthesis is accomplished through the following key steps: Nucleophilic ring-opening of 3-(4-chlorophenyl)-oxazolidin-2-one prepared by a one-pot procedure with 4-piperidinol and selective O-alkylation of 1-(2-(4-chlorophenylamino)ethyl)piperidin-4-ol. The obtained compound is a potent and selective IP agonist displaying a long duration of action.
- 1 December 2011
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 21 (24) , 7505-7508
Efficient synthesis of a novel m-phenylene derivative as a selective EP4 agonist inducing follicular growth and maturation in the ovary
- 1 December 2011
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 21 (24) , 7505-7508
Efficient synthesis of a novel m-phenylene derivative as a selective EP4 agonist inducing follicular growth and maturation in the ovary
- 1 August 2006
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 16 (15) , 4045-4047
Design and synthesis of selective α1B adrenoceptor antagonists
- 1 August 2006
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 16 (15) , 4045-4047
Design and synthesis of selective α1B adrenoceptor antagonists